(Q46663603)
Statements
Bezafibrate increases very-long-chain acyl-CoA dehydrogenase protein and mRNA expression in deficient fibroblasts and is a potential therapy for fatty acid oxidation disorders (English)
F Aubey
D Schlemmer
J P N Ruiter
R J A Wanders